BIOPHARMA PROCESS SYSTEMS LIMITEDActive
Key figures
BIOPHARMA PROCESS SYSTEMS LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £817,726 (74% of the profit for the year).
Filed accounts2023–2024
| 2023 | 2024 | |
|---|---|---|
| Profit for the year | 1,106,907 | 141,705 |
| Cash at bank and in hand | 5,120,662 | 4,232,170 |
| Total assets | 12,106,512 | 13,779,236 |
| Total liabilities | 2,602,828 | 4,045,675 |
| Net assets / total equity | 9,248,747 | 9,390,452 |
| Average number of employees | 60 | 66 |
| Average pay (per year) | 52,844 | 53,854 |
| Dividends paid | 817,726 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2024The principal activity of the company continued to be that of suppliers of specialist equipment to the process industries.
As described in the company's latest filed accounts.
Summary: BIOPHARMA PROCESS SYSTEMS LIMITED
Company
BIOPHARMA PROCESS SYSTEMS LIMITED is a private limited company registered with Companies House under company number 02337313. It was incorporated on 23 Jan 1989. Its status is active. The registered office is in Winchester (SO23). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files medium company accounts. Profit for the year was £141,705. Net assets were £9,390,452, up 1.5% on the previous year. Cash at bank and in hand was £4,232,170. Total assets were £13,779,236 and total liabilities £4,045,675. The company had an average of 66 employees. Figures are available for 2 financial years (2023–2024).
Control and charges
One person with significant control is registered. 5 of 6 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 31 Mar 2027.